The Annals Summaries of the Latest Medical Research!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 31, No. 11, pp. 1360-1369.
© 1997 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frackiewicz, E.
Right arrow Articles by Cutler, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frackiewicz, E.
Right arrow Articles by Cutler, N.


Research Articles

Ethnicity and antipsychotic response

EJ Frackiewicz, JJ Sramek, JM Herrera, NM Kurtz, and NR Cutler

OBJECTIVE: To review the data generated by studies examining interethnic/racial differences in response to antipsychotics. DATA SOURCES: A MEDLINE search (1966-1996) identified all articles examining differences in antipsychotic response among Caucasians, Asians, Hispanics, and African-Americans, as well as articles evaluating postulated mechanisms for these differences. STUDY SELECTION: All abstracts, studies, and review articles were evaluated. DATA SYNTHESIS: Ethnic/racial differences in response to antipsychotic medications have been reported and may be due to genetics, kinetic variations, dietary or environmental factors, or variations in the prescribing practices of clinicians. Studies suggest that Asians may respond to lower doses of antipsychotics due to pharmacokinetic and pharmacodynamic differences. Research relevant to African-Americans is limited, but some studies suggest that differences in this group may be due to clinician biases and prescribing practices, rather than to pharmacokinetic or pharmacodynamic variability. CONCLUSIONS: Future research directed at validating the hypotheses that different ethnic/racial groups show variations in response to antipsychotics should focus on homogeneous ethnic groups, use recent advances in pharmacogenetic testing, and control for such variables as observer bias, gender, disease chronicity, dietary and environmental factors, and exposure to enzyme-inducing and -inhibiting agents. Clinicians should be aware that potential interethnic/racial differences in pharmacodynamics and pharmacokinetics may exist that can alter response to antipsychotics.


This article has been cited by other articles:


Home page
Schizophr BullHome page
M. J. Arranz and S. Kapur
Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?
Schizophr Bull, August 27, 2008; (2008) sbn114v1.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
I. Chaudhry, K. Neelam, V. Duddu, and N. Husain
Ethnicity and psychopharmacology
J Psychopharmacol, August 1, 2008; 22(6): 673 - 680.
[Abstract] [PDF]


Home page
Journal of Pharmacy PracticeHome page
J. A. Rey
The Interface of Multiculturalism and Psychopharmacology
Journal of Pharmacy Practice, December 1, 2006; 19(6): 379 - 385.
[Abstract] [PDF]


Home page
Psychiatr. Serv.Home page
D. Garver, A. Lazarus, K. Rajagopalan, L. Lamerato, L. M. Katz, L. S. Stern, M. Dolgitser, and J. J. Doyle
Racial Differences in Medication Switching and Concomitant Prescriptions in the Treatment of Bipolar Disorder
Psychiatr Serv, May 1, 2006; 57(5): 666 - 672.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
E. H. Pi and G. M. Simpson
Psychopharmacology: Cross-Cultural Psychopharmacology: A Current Clinical Perspective
Psychiatr Serv, January 1, 2005; 56(1): 31 - 33.
[Full Text] [PDF]


Home page
J Clin PharmacolHome page
K. Kim, J. A. Johnson, and H. Derendorf
Differences in Drug Pharmacokinetics Between East Asians and Caucasians and the Role of Genetic Polymorphisms
J. Clin. Pharmacol., October 1, 2004; 44(10): 1083 - 1105.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
C.-Y. Wang, Z.-J. Zhang,, W.-B. Li, Y.-M. Zhai, Z.-J. Cai, Y.-Z. Weng, R.-H. Zhu, J.-P. Zhao, and H.-H. Zhou
The Differential Effects of Steady-State Fluvoxamine on the Pharmacokinetics of Olanzapine and Clozapine in Healthy Volunteers
J. Clin. Pharmacol., July 1, 2004; 44(7): 785 - 792.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
D. M. Herbeck, J. C. West, I. Ruditis, F. F. Duffy, D. J. Fitek, C. C. Bell, and L. R. Snowden
Variations in Use of Second-Generation Antipsychotic Medication by Race Among Adult Psychiatric Patients
Psychiatr Serv, June 1, 2004; 55(6): 677 - 684.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
W. E. Faison and D. Armstrong
Cultural Aspects of Psychosis in the Elderly
J Geriatr Psychiatry Neurol, December 1, 2003; 16(4): 225 - 231.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
G. L. Daumit, R. M. Crum, E. Guallar, N. R. Powe, A. B. Primm, D. M. Steinwachs, and D. E. Ford
Outpatient Prescriptions for Atypical Antipsychotics for African Americans, Hispanics, and Whites in the United States
Arch Gen Psychiatry, February 1, 2003; 60(2): 121 - 128.
[Abstract] [Full Text] [PDF]


Home page
J Am Psychiatr Nurses AssocHome page
W. J. Lutz and B. J. Warren
Symptomatology and Medication Monitoring for Public Mental Health Consumers: A Cultural Perspective
Journal of the American Psychiatric Nurses Association, August 1, 2001; 7(4): 115 - 124.
[Abstract] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1997 by Harvey Whitney Books Company.